RAYONIER ADVANCED MATERIALS INC
For the period ended Dec 31, 2024. Filed Mar 6, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Rayonier Advanced Materials Inc. | |
| By: | /s/ MARCUS J. MOELTNER |
| Marcus J. MoeltnerChief Financial Officer and Senior Vice President, Finance |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ DE LYLE W. BLOOMQUIST | Chief Executive Officer, Presidentand Director | March 6, 2025 |
| De Lyle W. Bloomquist(Principal Executive Officer) | ||
| /s/ MARCUS J. MOELTNER | Chief Financial Officer andSenior Vice President, Finance | March 6, 2025 |
| Marcus J. Moeltner(Principal Financial Officer) | ||
| /s/ GABRIELA GARCIA | Chief Accounting Officer andVice President, Corporate Controller | March 6, 2025 |
| Gabriela Garcia(Principal Accounting Officer) | ||
Power of Attorney
KNOW ALL MEN BY THESE PRESENTS, that the persons whose signatures appear below constitute and appoint Marcus J. Moeltner and R. Colby Slaughter, his/her true and lawful attorneys-in-fact, with full power in each to act without the other and with full power of substitution and resubstitution, to sign in the name of such person and in each of his/her offices and capacities with Rayonier Advanced Materials Inc., the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, together with any amendments thereto, and to file same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ LISA M. PALUMBO | Chair | January 24, 2025 |
| Lisa M. Palumbo | ||
| /s/ ERIC M. BOWEN | Director | January 27, 2025 |
| Eric M. Bowen | ||
| /s/ JULIE A. DILL | Director | January 24, 2025 |
| Julie A. Dill | ||
| /s/ CHARLES R. EGGERT | Director | January 26, 2025 |
| Charles R. Eggert | ||
| /s/ JAMES F. KIRSCH | Director | January 24, 2025 |
| James F. Kirsch | ||
| /s/ DAVID C. MARIANO | Director | January 24, 2025 |
| David C. Mariano | ||
| /s/ IVONA SMITH | Director | January 24, 2025 |
| Ivona Smith | ||
| /s/ BRYAN D. YOKLEY | Director | January 29, 2025 |
| Bryan D. Yokley | ||
Index to Financial Statements
| Page | |
| Management’s Report on Internal Control over Financial Reporting | F-2 |
|---|---|
| Reports of Independent Registered Public Accounting Firm (PCAOB ID Number 248) | F-3 |
| Consolidated Statements of Operations | F-7 |
| Consolidated Statements of Comprehensive Income (Loss) | F-8 |
| Consolidated Balance Sheets | F-9 |
| Consolidated Statements of Stockholders' Equity | F-10 |
| Consolidated Statements of Cash Flows | F-11 |
| Notes to Financial Statements | F-13 |
| Index to Financial Statement Schedules | |
| Schedule II - Valuation and Qualifying Accounts | F-53 |
| All other financial statement schedules are omitted because they are not applicable or the required information is otherwise supplied in the Financial Statements or the notes thereto. | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.